Preemptive Meds Private Limited - Company Profile

It is a business services private limited company based in Kottayam, Kerala, India, established in 2011.
2011 Kottayam, Kerala, India Active
Last Updated:
Access Report
About Preemptive Meds Private Limited

Preemptive Meds Private Limited, a active private limited company, was established on 30 September 2011 in Kottayam, Kerala, India. Engaging in csw professional within the professional, scientific and technical sector, it holds CIN: U24100KL2011PTC029481. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes George Fenn (Director), Jessy Fenn George (Director), Joe George Fenn (Director). Past directors included Joe George Fenn. It holds no open charges and ₹1.20 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Thoppil House Vazhoor Post, Kottayam, Kerala, 686504.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100KL2011PTC029481

  • Registration Number

    029481

  • Incorporation Date

    30 September 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.20 M
  • Revenue Growth **** 860.08%
  • Profit Growth **** 2521.35%
  • Ebitda **** 1389.47%
  • Net Worth 39.77%
  • Total Assets **** 53.87%
Company report

Preemptive Meds Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Preemptive Meds Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Preemptive Meds Private Limited?
Current Directors
Name Designation Appointment Date Status
George Fenn Director 30 Sep 2011 Current
Jessy Fenn George Director 30 Sep 2011 Current
Joe George Fenn Director 02 Dec 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Preemptive Meds.

Preemptive Meds Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 860.08% increase. The company also saw a substantial improvement in profitability, with a 2521.35% increase in profit. The company's net worth Soared by an impressive increase of 39.77%.

Preemptive Meds revenue growth over time
Preemptive Meds profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 860.08%
*******
*******
*******
*******
Revenue from Operations
*******
 999.82%
*******
*******
*******
*******
Total Assets
*******
 53.87%
*******
*******
*******
*******
Profit or Loss
*******
 2521.35%
*******
*******
*******
*******
Net Worth
*******
 39.77%
*******
*******
*******
*******
EBITDA
*******
 1389.47%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Preemptive Meds?

In 2017, Preemptive Meds had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹1,200,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.12 Cr
Latest Charge Details
Date Lender Amount Status
07 Nov 2019 Others ₹1.20 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Preemptive Meds?

Unlock and access historical data on people associated with Preemptive Meds, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Preemptive Meds, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Preemptive Meds's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Preemptive Meds
Recent Activity within the Organization
  • Annual General Meeting

    The activity Preemptive Meds Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Preemptive Meds Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was documented.

  • Charges

    The activity A charge registered on 07 Nov 2019 via Charge ID 100302611 with Others was fully satisfied on 18 Apr 2024. was completed.

  • Director Appointment

    The activity Joe George Fenn was appointed as a Director was appointed as a Director on 02 Dec 2019 & has been associated with this company since 6 years 2 months . was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 1.20 M with Charge ID 100302611 was registered on 07 Nov 2019. was completed.

  • Director Appointment

    The activity George Fenn was appointed as a Director was appointed as a Director on 30 Sep 2011 & has been associated with this company since 14 years 4 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Preemptive Meds Private Limited?

The CIN of Preemptive Meds Private Limited is U24100KL2011PTC029481.

Where is Preemptive Meds Private Limited headquartered?

Preemptive Meds Private Limited is headquartered at Thoppil House Vazhoor Post, Kottayam, Kerala, 686504.

When was Preemptive Meds Private Limited incorporated?

Preemptive Meds Private Limited was incorporated on 30 September 2011.

Who are the current directors of Preemptive Meds Private Limited?

The current directors of Preemptive Meds Private Limited are

What is the primary industry of Preemptive Meds Private Limited?

The primary industry of Preemptive Meds Private Limited is Professional, Scientific And Technical.

Is Preemptive Meds Private Limited a listed company?

Preemptive Meds Private Limited is unlisted.

What is the capital structure of Preemptive Meds Private Limited?

The authorized capital of Preemptive Meds Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Preemptive Meds Private Limited?

The compliance status of Preemptive Meds Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available